When staining MDA-MB-468 tumors for the endothelial marker CD31, we found that RALB but not RALA loss decreased CD31 expression within both tumoral and stromal regions, suggesting that RALB may support angiogenesis in vivo and its silencing may impede tumor growth. This evidence concerns the gene RALA and neoplasm.